1036 related articles for article (PubMed ID: 15943939)
1. Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome.
Jones HE; Johnson RE; Jasinski DR; O'Grady KE; Chisholm CA; Choo RE; Crocetti M; Dudas R; Harrow C; Huestis MA; Jansson LM; Lantz M; Lester BM; Milio L
Drug Alcohol Depend; 2005 Jul; 79(1):1-10. PubMed ID: 15943939
[TBL] [Abstract][Full Text] [Related]
2. Buprenorphine and methadone treatment of opiate dependence during pregnancy: comparison of fetal growth and neonatal outcomes in two consecutive case series.
Kakko J; Heilig M; Sarman I
Drug Alcohol Depend; 2008 Jul; 96(1-2):69-78. PubMed ID: 18355989
[TBL] [Abstract][Full Text] [Related]
3. Methadone versus buprenorphine in pregnant addicts: a double-blind, double-dummy comparison study.
Fischer G; Ortner R; Rohrmeister K; Jagsch R; Baewert A; Langer M; Aschauer H
Addiction; 2006 Feb; 101(2):275-81. PubMed ID: 16445556
[TBL] [Abstract][Full Text] [Related]
4. Prospective randomised comparative study of the effect of buprenorphine, methadone and heroin on the course of pregnancy, birthweight of newborns, early postpartum adaptation and course of the neonatal abstinence syndrome (NAS) in women followed up in the outpatient department.
Binder T; Vavrinková B
Neuro Endocrinol Lett; 2008 Feb; 29(1):80-6. PubMed ID: 18283247
[TBL] [Abstract][Full Text] [Related]
5. Opioid maintenance treatment during pregnancy: occurrence and severity of neonatal abstinence syndrome. A national prospective study.
Bakstad B; Sarfi M; Welle-Strand GK; Ravndal E
Eur Addict Res; 2009; 15(3):128-34. PubMed ID: 19332991
[TBL] [Abstract][Full Text] [Related]
6. Management of neonatal abstinence syndrome in neonates born to opioid maintained women.
Ebner N; Rohrmeister K; Winklbaur B; Baewert A; Jagsch R; Peternell A; Thau K; Fischer G
Drug Alcohol Depend; 2007 Mar; 87(2-3):131-8. PubMed ID: 17000060
[TBL] [Abstract][Full Text] [Related]
7. Randomized controlled study transitioning opioid-dependent pregnant women from short-acting morphine to buprenorphine or methadone.
Jones HE; Johnson RE; Jasinski DR; Milio L
Drug Alcohol Depend; 2005 Apr; 78(1):33-8. PubMed ID: 15769555
[TBL] [Abstract][Full Text] [Related]
8. Differences in the profile of neonatal abstinence syndrome signs in methadone- versus buprenorphine-exposed neonates.
Gaalema DE; Scott TL; Heil SH; Coyle MG; Kaltenbach K; Badger GJ; Arria AM; Stine SM; Martin PR; Jones HE
Addiction; 2012 Nov; 107 Suppl 1(0 1):53-62. PubMed ID: 23106927
[TBL] [Abstract][Full Text] [Related]
9. Neonatal abstinence syndrome after methadone or buprenorphine exposure.
Jones HE; Kaltenbach K; Heil SH; Stine SM; Coyle MG; Arria AM; O'Grady KE; Selby P; Martin PR; Fischer G
N Engl J Med; 2010 Dec; 363(24):2320-31. PubMed ID: 21142534
[TBL] [Abstract][Full Text] [Related]
10. [Buprenorphine in pregnancy].
Eder H; Rupp I; Peternell A; Fischer G
Psychiatr Prax; 2001 Sep; 28(6):267-9. PubMed ID: 11533891
[TBL] [Abstract][Full Text] [Related]
11. [Withdrawal syndromes of newborns of pregnant drug abusers maintained under methadone or high-dose buprenorphine: 246 cases].
Lejeune C; Aubisson S; Simmat-Durand L; Cneude F; Piquet M; Gourarier L;
Ann Med Interne (Paris); 2001 Nov; 152 Suppl 7():21-7. PubMed ID: 11965095
[TBL] [Abstract][Full Text] [Related]
12. Neonatal outcomes following in utero exposure to methadone or buprenorphine: a National Cohort Study of opioid-agonist treatment of Pregnant Women in Norway from 1996 to 2009.
Welle-Strand GK; Skurtveit S; Jones HE; Waal H; Bakstad B; Bjarkø L; Ravndal E
Drug Alcohol Depend; 2013 Jan; 127(1-3):200-6. PubMed ID: 22841456
[TBL] [Abstract][Full Text] [Related]
13. A Retrospective Cohort Study of Birth Outcomes in Neonates Exposed to Naltrexone in Utero: A Comparison with Methadone-, Buprenorphine- and Non-opioid-Exposed Neonates.
Kelty E; Hulse G
Drugs; 2017 Jul; 77(11):1211-1219. PubMed ID: 28536981
[TBL] [Abstract][Full Text] [Related]
14. Randomized controlled trials in pregnancy: scientific and ethical aspects. Exposure to different opioid medications during pregnancy in an intra-individual comparison.
Unger A; Jagsch R; Jones H; Arria A; Leitich H; Rohrmeister K; Aschauer C; Winklbaur B; Bäwert A; Fischer G
Addiction; 2011 Jul; 106(7):1355-62. PubMed ID: 21438938
[TBL] [Abstract][Full Text] [Related]
15. Design considerations for point-of-care clinical trials comparing methadone and buprenorphine treatment for opioid dependence in pregnancy and for neonatal abstinence syndrome.
Winhusen T; Wilder C; Wexelblatt SL; Theobald J; Hall ES; Lewis D; Van Hook J; Marcotte M
Contemp Clin Trials; 2014 Sep; 39(1):158-65. PubMed ID: 25183042
[TBL] [Abstract][Full Text] [Related]
16. [Drug withdrawal in newborns - clinical data of 49 infants with intrauterine drug exposure: what should be done?].
Bläser A; Pulzer F; Knüpfer M; Robel-Tillig E; Vogtmann C; Nickel P; Kiess W
Klin Padiatr; 2008; 220(5):308-15. PubMed ID: 18260044
[TBL] [Abstract][Full Text] [Related]
17. Association between prenatal tobacco exposure and outcome of neonates born to opioid-maintained mothers. Implications for treatment.
Winklbaur B; Baewert A; Jagsch R; Rohrmeister K; Metz V; Aeschbach Jachmann C; Thau K; Fischer G
Eur Addict Res; 2009; 15(3):150-6. PubMed ID: 19420947
[TBL] [Abstract][Full Text] [Related]
18. Maternal methadone use in pregnancy: factors associated with the development of neonatal abstinence syndrome and implications for healthcare resources.
Dryden C; Young D; Hepburn M; Mactier H
BJOG; 2009 Apr; 116(5):665-71. PubMed ID: 19220239
[TBL] [Abstract][Full Text] [Related]
19. Neonatal abstinence syndrome.
Jansson LM; Velez M
Curr Opin Pediatr; 2012 Apr; 24(2):252-8. PubMed ID: 22227786
[TBL] [Abstract][Full Text] [Related]
20. [Neonatal abstinence syndrome and maternal toxicological profile].
Fundarò C; Solinas A; Martino AM; Genovese O; Noia G; Conte GL; Segni G
Minerva Pediatr; 1994 Mar; 46(3):83-8. PubMed ID: 8035762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
